Zomedica Pharmaceuticals (AMEX:ZOM) reported quarterly sales of $6.20 million which met the analyst consensus estimate. This is a 51.92 percent increase over sales of $4.08 million the same period last year.
Why Cano Health Shares Are Trading Lower By Around 23%? Here Are Other Stocks Moving In Thursday’s Mid-Day Session
Gainers
Exela Technologies, Inc. (NASDAQ: XELA) shares surged 45% to $0.0701 after the company announced $51 million of new funding, amendment increases existing securitization facility to $185 million and other related transactions.
